A detailed history of Thoroughbred Financial Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 17,573 shares of BMY stock, worth $1.02 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
17,573
Previous 10,353 69.74%
Holding current value
$1.02 Million
Previous $430,000 111.4%
% of portfolio
0.06%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $286,345 - $373,635
7,220 Added 69.74%
17,573 $909,000
Q2 2024

Aug 08, 2024

BUY
$40.25 - $52.99 $36,265 - $47,743
901 Added 9.53%
10,353 $430,000
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $654,591 - $742,179
-13,643 Reduced 59.07%
9,452 $512,000
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $51,631 - $61,610
1,065 Added 4.83%
23,095 $1.19 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $475,682 - $531,886
8,217 Added 59.49%
22,030 $1.28 Million
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $112,448 - $124,856
-1,765 Reduced 11.33%
13,813 $883,000
Q1 2023

Apr 24, 2023

BUY
$65.71 - $74.53 $61,964 - $70,281
943 Added 6.44%
15,578 $1.08 Million
Q4 2022

Feb 07, 2023

BUY
$68.48 - $81.09 $77,998 - $92,361
1,139 Added 8.44%
14,635 $1.05 Million
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $252,935 - $278,570
3,483 Added 34.78%
13,496 $1.04 Million
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $180,689 - $216,663
2,939 Added 41.55%
10,013 $731,000
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $41,134 - $47,952
-767 Reduced 9.78%
7,074 $441,000
Q3 2021

Oct 27, 2021

BUY
$59.17 - $69.31 $14,496 - $16,980
245 Added 3.23%
7,841 $463,000
Q2 2021

Jul 27, 2021

SELL
$61.91 - $67.42 $15,725 - $17,124
-254 Reduced 3.24%
7,596 $508,000
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $101,946 - $114,659
1,718 Added 28.02%
7,850 $495,000
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $53,467 - $60,588
-926 Reduced 13.12%
6,132 $380,000
Q3 2020

Oct 28, 2020

BUY
$57.43 - $63.64 $5,168 - $5,727
90 Added 1.29%
7,058 $425,000
Q2 2020

Jul 20, 2020

SELL
$54.82 - $64.09 $31,466 - $36,787
-574 Reduced 7.61%
6,968 $410,000
Q1 2020

Apr 23, 2020

BUY
$46.4 - $67.43 $46 - $67
1 Added 0.01%
7,542 $420,000
Q4 2019

Feb 05, 2020

SELL
$49.21 - $64.19 $6,151 - $8,023
-125 Reduced 1.63%
7,541 $484,000
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $6,843 - $8,113
-160 Reduced 2.04%
7,666 $389,000
Q2 2019

Jul 16, 2019

SELL
$44.62 - $49.34 $15.5 Million - $17.1 Million
-347,090 Reduced 97.79%
7,826 $0
Q2 2019

Jul 16, 2019

BUY
$44.62 - $49.34 $15.4 Million - $17 Million
345,037 Added 3492.63%
354,916 $0
Q1 2019

May 07, 2019

SELL
$45.12 - $53.8 $49,541 - $59,072
-1,098 Reduced 10.0%
9,879 $471,000
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $535,238 - $694,075
10,977 New
10,977 $570,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.